Magenta Therapeutics

December 06, 2018

Ash 2018 event analyzer – Losers edge out winners in year’s final major meeting

Autolus leads winners in spite of scepticism over its CAR-T, and gene therapies disappoint.

November 21, 2018

Ash 2018 preview – smaller groups get their turn in the spotlight

Swedish Orphan Biovitrum made waves yesterday by getting its rare disease asset emapalumab into the Ash late-breakers – and bagging approval soon afterwards.

July 02, 2018

June rush drives near-record quarter for biotech flotations

Biotech IPOs raised a huge $2.3bn on Western exchanges in the second-quarter of 2018, as private companies rushed to market ahead of the summer lull.

Magenta Therapeutics

Ash 2018 event analyzer – Losers edge out winners in year’s final major meeting

Ash 2018 preview – smaller groups get their turn in the spotlight

June rush drives near-record quarter for biotech flotations

Latest Reports

Evaluate Vantage COVID-19 Report

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

Editor's Picks

Covid-19 antibody tests face a very specific problem

Covid-19’s clinical damage starts to emerge

The crucial data readouts coming soon for small biotechs

AACR 2020 preview – no Tigit, but plenty of novel mechanisms

The long path to an effective coronavirus vaccine